An 18-Week Randomized, Double-Blind, Multicenter, Comparator Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus.
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Diasome Pharmaceuticals
- 07 Jun 2017 Biomarkers information updated
- 01 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Jan 2009 New trial record.